Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1997-10-17
1999-10-19
Reamer, James H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514177, 514178, 514369, 514652, A61K 3158
Patent
active
059689188
ABSTRACT:
The present invention relates to the prevention of coronary artery spasm in mammals by the administration of an effective amount of an antiestrogen compound to block estrogen receptors for the reduction or prevention of the formation of an estrogen--estrogen receptor complex so that estrogen response elements in the DNA of the smooth muscle of the coronary arteries is not activated by the complex. The method of the invention is used to reduce the risk of spasm induced cardiac problems such as sudden infant death syndrome. The antiestrogen is selected from the group consisting of progestins and nonsteroidal antiestrogen compounds.
REFERENCES:
patent: 4729999 (1988-03-01), Young
patent: 5472985 (1995-12-01), Grainger et al.
patent: 5512557 (1996-04-01), Collins
patent: 5733925 (1998-03-01), Knuz et al.
I. Kanda, M. Endo Coronary Artery Spasm: a Hypothesis on Prevention by Progesterone, Medical Hypothesis, 49, 183-185, Aug. 1997.
Reamer James H.
Vanderburgh John E.
LandOfFree
Method for the prevention of coronary artery spasm does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for the prevention of coronary artery spasm, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the prevention of coronary artery spasm will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2055501